Vnitr Lek 2008, 54(11):1059-1062

Place of inhibin B investigation in clinical andrological praxis

I. Poršová-Dutoit
Šilinkův nadační fond Praha, vedoucí prof. MUDr. RNDr. Luboslav Stárka, DrSc.

Inhibin B is a gonadal dimeric peptide, produced in men in testicular Sertolli cells. Inhibin B blood level knowledge can be a useful tool in the management of difficult diagnostic problems, such as ambiguous genitalia, the distinction between cryptorchidism and anorchidism and the hypogonadotrophic hypogonadism/delayed puberty differential diagnosis. Inhibin B measurements can help in gonadal dysgenesis evaluation, androgen insensitivity management and also in the diagnosis of some gonadal tumors. In adult men, inhibin B evaluation is helpful in the investigation of male infertility, especially in the judgment of the pro-gnosis of testicular biopsy in in-vitro fertilization programs. Although commercial kits for inhibin B measurement are available at present, its evaluation is accessible in the Czech Republic for the time being in only very limited number of laboratory centers.

Keywords: inhibin; ambiguous genitalia; cryptorchidism; puberty; gonadal tumors; infertility

Received: May 2, 2008; Accepted: July 7, 2008; Published: November 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Poršová-Dutoit I. Place of inhibin B investigation in clinical andrological praxis. Vnitr Lek. 2008;54(11):1059-1062.
Download citation

References

  1. Adan L, Couto-Silva AC, Trivin C et al. Congenital gonadotropin deficiency in boys: management during childhood. J Pediatr Endocrinol Metab 2004; 17: 149-155. Go to original source... Go to PubMed...
  2. Andersson AM, Toppari J, Haavisto AM et al. Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 1998; 83: 675-661. Go to original source...
  3. Arrigo T, Pirazzoli P, De Sanctis L et al. McCune-Albright syndrome in a boy may present with a monolateral macroorchidism as an early and isolated clinical manifestation. Horm Res 2006; 65: 114-119. Go to original source... Go to PubMed...
  4. Babčová K, Ulčová-Gallová Z, Červenková Z et al. Inhibin B and intraacrosomal proteins in men from the couples with fertility disorders. Čes Gynekol 2006; 71: 111-117.
  5. Bauer J, Blumenthal S, Reuber M et al. Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy. Neurology 2004; 62: 243-246. Go to original source... Go to PubMed...
  6. Bohring C, Schroeder-Printzen I, Weidner W et al. Serum levels of inhibin B and follicle-stimulating hormone may predict successful sperm retrieval in men with azoo-spermia who are undergoing testicular sperm extraction. Fertil Steril 2002; 78: 1195-1198. Go to original source... Go to PubMed...
  7. Bouvattier C, Carel JC, Lecointre C et al. Postnatal changes of T, LH, and FSH in 46,XY infants with mutations in the AR gene. J Clin Endocrinol Metab 2002; 87: 29-32. Go to original source... Go to PubMed...
  8. Cortes D, Thorup J, Hogdall E et al. The relation of germ cells per tubule in testes, serum inhibin B and FSH in cryptorchid boys. Pediatr Surg Int 2007; 23: 163-169. Go to original source... Go to PubMed...
  9. Coutant R, Lumbroso S, Rey R et al. Macroorchidism due to autonomous hyperfunction of Sertoli cells and G(s)alpha gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy. J Clin Endocrinol Metab 2001; 86: 1778-1781. Go to original source...
  10. Červenková Z, Ulčová-Gallová Z, Babcová K et al. Present knowledge on inhibins B and A. Čes gynekol 2006; 71: 79-82.
  11. Gray PC, Greenwald J, Blount AL et al. Identification of a binding site on the type II activin receptor for activin and inhibin. J Biol Chem 2000; 275: 3206-3212. Go to original source... Go to PubMed...
  12. Groome NP, Tsigou A, Cranfield M et al. Enzyme immunossays for inhibins, activins and follistations. Mol Cell Endocrinol 2001; 180: 73-77. Go to original source... Go to PubMed...
  13. Hemminki A, Markie D, Tomlinson I et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391: 184-187. Go to original source... Go to PubMed...
  14. Hurwitz JM, Santoro N. Inhibins, activins, and follistatin in the aging female and male. Semin Reprod Med 2004; 22: 209-217. Go to original source... Go to PubMed...
  15. Chada M, Průša R, Bronský J et al. Inhibin B, follicle stimulating hormone, luteinizing hormone and testosterone during childhood and puberty in males: changes in serum concentrations inrelation to age and stage of puberty. Physiol Res 2003; 52: 45-51. Go to original source...
  16. Christiansen P, Andersson AM, Skakkebaek NE et al. Serum inhibin B, FSH, LH and testosterone levels before and after human chronic gonadotropin stimulation in prepubertal boys with cryptorchidism. Eur J Endocrinol 2002; 147: 95-101. Go to original source... Go to PubMed...
  17. Christiansen P, Andersson AM, Skakkebaek NE. Longitudinal studies of inhibin B levels in boys and young adults with Klinefelter syndrome. J Clin Endocrinol Metab 2003; 88: 888-891. Go to original source... Go to PubMed...
  18. Iczkowski KA, Bostwick DG, Roche PC et al. Inhibin A is a sensitive and specific marker for testicular sex cord-stromal tumors. Mod Pathol 1998; 11: 774-779.
  19. Illingworth PJ, Groome NP, Byrd W et al. Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 1996; 81: 1321-1325. Go to original source...
  20. Kubini K, Zachmann M, Albers N et al. Basal inhibin B and the testosterone response to human chorionic gonadotropin correlate in prepubertal boys. J Clin Endocrinol Metab 2000; 85: 134-138. Go to original source...
  21. Lahlou N, Fennoy I, Carel JC et al. Inhibin B and anti-Müllerian hormone, but not testosterone levels, are normal in infants with nonmosaic Klinefelter syndrome. J Clin Endocrinol Metab 2004; 894: 1864-1868. Go to original source... Go to PubMed...
  22. Lahlou N, Roger M. Inhibin B in pubertal development and pubertal disorders. Semin Reprod Med 2004; 22: 165-176. Go to original source... Go to PubMed...
  23. Lefevre H, Bouvattier C, Lahlou N et al. Prepubertal gynecomastia in Peutz-Jeghers syndrome: incomplete penetrance in a familial case and management with an aromatase inhibitor. Eur J Endocrinol 2006; 154: 221-227. Go to original source... Go to PubMed...
  24. Lockwood G. The diagnostic value of inhibin in infertility evaluation. Semin Reprod Med 2004; 22: 195-208. Go to original source... Go to PubMed...
  25. Meachem SJ, Nieschlag E, Simoni M. Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol 2001; 145: 561-571. Go to original source... Go to PubMed...
  26. Meikle AW. The interrelationships between thyroid dysfunction and hypogonadism in men and boys. Thyroid 2004; 14 (Suppl 1): S17-S25. Go to original source... Go to PubMed...
  27. McCullagh DR. Dual endocrine activity of the testes. Science 1932; 76: 19-20. Go to original source... Go to PubMed...
  28. Misra M, MacLaughlin DT, Donahoe PK et al. Measurement of Mullerian inhibiting substance facilitates management of boys with microphallus and cryptorchidism. J Clin Endocrinol Metab 2002; 87: 3598-3602. Go to original source... Go to PubMed...
  29. O'Connor AE, de Kretser DM. Inhibins in normal male physiology. Semin Reprod Med 2004; 22: 177-185. Go to original source... Go to PubMed...
  30. Pauli EM, Legro RS, Demers LM et al. Diminished paternity and gonadal function with increasing obesity in men. Fertil Steril 2008; Epub Feb 19. Go to original source... Go to PubMed...
  31. Pierik FH, Abdesselam SA, Vreeburg JT et al. Increased serum inhibin B levels after varicocele treatment. Clin Endocrinol (Oxf) 2001; 54: 775-780. Go to original source... Go to PubMed...
  32. Pigny P, Dewailly D, Racadot A et al. Famille des inhibines et des activines: de I'action endocrine à I'action paracrine. Ann Endocrinol (Paris) 1996; 57: 385-394. Go to PubMed...
  33. Pitteloud N, Hayes FJ, Boepple PA et al. The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2002; 87: 152-160. Go to original source... Go to PubMed...
  34. Poršová-Dutoit I. Male hormonal contraception. Vnitř Lék 2006; 52: 1077-1084. Go to PubMed...
  35. Rajpert-De Meyts E, Jørgensen N, Graem N et al. Expression of anti-Müllerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 1999; 84: 3836-3844. Go to original source...
  36. Rey R. How to evaluate gonadal function in the cryptorchid boy. Lessons from new testicular markers. J Pediatr Endocrinol Metab 2003; 16: 357-364. Go to original source... Go to PubMed...
  37. Rey R, Mebarki F, Forest MG et al. Anti-müllerian hormone in children with androgen insensitivity. J Clin Endocrinol Metab 1994; 79: 960-964. Go to original source...
  38. Risbridger GP, Schmitt JF, Robertson DM. Activins and inhibins in endocrine and other tumors. Endocr Rev 2001; 22: 836-858. Go to original source... Go to PubMed...
  39. Schmiegelow M, Lassen S, Poulsen HS et al. Gonadal status in male survivors following childhood brain tumors. J Clin Endocrinol Metab 2001; 86: 2446-2452. Go to original source...
  40. Schneyer A. Inhibins: a historical perspective. Semin Reprod Med 2004; 22: 161-164. Go to original source... Go to PubMed...
  41. Shenker A, Laue L, Kosugi S et al. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993; 365: 652-654. Go to original source... Go to PubMed...
  42. Soriano-Guillen L, Mitchell V, Carel JC et al. Activating mutations in the LH receptor gene: a human model of non FSH-dependent inhibin production and germ cell maturation. J Clin Endocrinol Metab 2006; 91: 3041-3047. Go to original source... Go to PubMed...
  43. Vale W, Rivier C, Hsueh A et al. Chemical and biological characterization of the inhibins family of protein hormones. Recent Prog Horm Res 1988; 44: 1-34. Go to original source... Go to PubMed...
  44. Ying SY. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev 1988; 9: 267-293. Go to original source... Go to PubMed...
  45. Young J, Couzinet B, Chanson P et al. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. J Clin Endocrinol Metab 2000; 85: 3239-3244. Go to original source... Go to PubMed...
  46. Young J, Chanson P, Salenave S et al. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2005; 90: 724-728. Go to original source... Go to PubMed...
  47. Žofková I, Bubeníček P, Sotorník I. Hypogonadism, a serious complication of chronic renal insufficiency. Vnitř Lék 2007; 53: 709-14. Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.